IE
OYST

Israel Englander’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Israel Englander’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-206,254
Closed -$2.3M – 7443
2022
Q4 		$2.3M Buy
206,254
+99,703
+94% +$966K ﹤0.01% 3459
2022
Q3 		$599K Sell
106,551
-28,087
-21% -$176K ﹤0.01% 4802
2022
Q2 		$583K Buy
+134,638
New +$765K ﹤0.01% 4829
2022
Q1 		– Sell
-119,783
Closed -$2.19M – 7934
2021
Q4 		$2.19M Buy
119,783
+81,611
+214% +$1.04M ﹤0.01% 3697
2021
Q3 		$452K Buy
38,172
+2,613
+7% +$38.1K ﹤0.01% 5450
2021
Q2 		$611K Sell
35,559
-23,129
-39% -$440K ﹤0.01% 5127
2021
Q1 		$1.07M Sell
58,688
-47,580
-45% -$998K ﹤0.01% 4151
2020
Q4 		$2M Sell
106,268
-56,547
-35% -$1.22M ﹤0.01% 3238
2020
Q3 		$3.44K Buy
162,815
+35,505
+28% +$830K ﹤0.01% 2166
2020
Q2 		$3.68M Buy
127,310
+120,898
+1,885% +$3.64M 0.01% 2047
2020
Q1 		$224K Sell
6,412
-3,705
-37% -$120K ﹤0.01% 3330
2019
Q4 		$247K Buy
+10,117
New +$178K ﹤0.01% 3763

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Israel Englander's OYST Position: Q1 2023 in Review

Israel Englander sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 206,254 shares — an estimated $2.3M sold.

Israel Englander first reported a position in OYST in Q4 2019 and held it in 12 quarters. The position peaked at $3.68M in Q2 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Israel Englander reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 206,254 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.3M.
  • Israel Englander first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Israel Englander's Oyster Point Pharma, Inc. Common Stock position peaked at $3.68M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.